Knowledge on small-cell lung cancer.
First, let’s see what small cell lung cancer is. Small-cell lung cancer is a type of lung cancer that originates from bronchial mucous membranes or glands, with minimal tumour cells in pathological expression, low cell plasma, very rapid progress in clinical expression diseases, a relatively short natural pathology, most of which has already been transferred at the time of diagnosis, high sensitivity to chemotherapy, but is easily re-emergence after treatment, with poor prognosis. Small-cell lung cancer is more readily transmitted than non-small-cell lung cancer, with the main clinical manifestations being respiratory symptoms, including coughing, breathing difficulties or coughing blood. Images show pulmonary oedema in the centre, frequent lymphoma knots and lymphoma knots, with 70 per cent of patients at the end of the initial diagnosis and the most common transfer areas including the side lung, the brain, the liver, the adrenal gland and the bone. Small-cell lung cancer is of limited duration and duration, with a high degree of malignant small-cell lung cancer over a broad period of time, a high risk of relapse after treatment and a low survival rate of 1.6 per cent over five years. But now in the age of immunization, the combination of immunotherapy has significantly increased the survival rate for five years. Let’s find out what the symptoms of small cell lung cancer are. 1. Smoking, smoking or passive smoking can lead to small-cell lung cancer, and the probability of a disease increases with increased smoking, early smoking age and extended smoking age. 2. Air pollution, indoor environments, and substances from cooking or fuel combustion, are at risk of carcinogenicity, and outdoor environments, such as those in industrial exhausts, can contaminate the atmosphere, especially when fine particulate matter may contain, for example, arsenic oxide or radioactive substances, and fatty hydrocarbons. Occupational carcinogenic factors, such as industrially produced substances, asbestos, kerosene, trichloroether, etc., as well as microwave and ionizing radiation. These carcinogenic factors can increase the risk of lung cancer by 3 to 30 times, from exposure to these substances to the time of lung cancer and to the extent of exposure to these substances, with a longer period of incubation, which may also occur years after the exposure has ceased. 4. Genetic and genetic mutations, the activation of the original cancer gene and the failure of the cancer gene, as a result of which cell growth is out of control, are inhibited by cell collapse. Ionizing radiation, with large doses of ionizing radiation, may also cause lung cancer, but the effects of different rays vary. Other contributing factors, such as tuberculosis, repeated lung infections and male obstructive lung cancer, can lead to small cell lung cancer. What are the typical symptoms of small cell lung cancer? Cough is an early symptom, with approximately 50 to 70 per cent of patients, small-cell lung cancer and atmospheric tracts, so the cough is mostly irritated and is accompanied by cough, small, medium or large. 2. Sluice or carving occurs in approximately 25 to 50 per cent of the population, because the tumour cell is relatively low and invasive, and is growing in the cavity at an early stage, which can lead to blood in the tumour, clots, and even in the case of a tumour when the surface is heavier. 3. Respiratory difficulties or asthma, with approximately 25 per cent of patients occurring, caused by partial air-traffic congestion. The general antibiotic treatment is not effective due to fever, most of which is the result of a fatal tumour tissue or obstructive pneumonia. 5. The sound is mute, the tumour is either directly repressed or transferred to the lympholytic concussion to the nerve. chest pains, which may occur in about 10 per cent of patients, are due to tumours and pleural dysenters or to obstruct the return of lymphoma. The difficulty of swallowing, which can occur when a tumour violates or oppresses a dish. 8. Declines in body weight and the most common symptoms in the advanced stages of malignant tumours can be seen in wasting and maladies. In addition, small-cell lung cancer may be associated with other symptoms, such as bone transfer, central nervous system transfer, adrenal gland transfer, liver transfer, lymphosis transfer, etc. There are no early symptoms of small-cell lung cancer, and a routine medical check-up is required, or a chest-image examination is necessary for further diagnosis, especially among smokers, and a CT examination of the lungs is recommended for six months. The routine check-up of small-cell lung cancers includes: blood routines, examination of coagulation function, sapling tests, tumour markings, chest CT flattening, enhanced CT examinations, MRI imaging, whole body PET-CT examinations, bronchoscopy examination, chest cavity lens examination, etc. The most common treatments for small-cell lung cancer are those of medical treatment, chemotherapy and immunotherapy. Of all lung cancers, small-cell lung cancer is the most sensitive to leaching, and breast-laying increases the lifetime of patients with limited duration. The drugs commonly used in small-cell first-line chemotherapy are platinum platinum, which is also an effective first-line treatment for small-cell lung cancer for a wide range of periods. In addition, immunization treatment has increased the overall survival rate for a wide range of small-cell lung cancers, which are now the most important treatment for a wide range of small-cell lung cancers. In general, the early transfer of small-cell lung cancer, the re-emergence of treatment and the subsequent deterioration have become a deadly subtype of lung cancer, so early detection and early diagnosis and treatment are important for slowing progress and improving the survival and quality of life of patients.
